ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcare● Active

$21.34

$-0.22(-1.03%)

Market Cap$3.7B

P/E Ratio—

52W High$28.35

52W Low$19.69

Avg Volume1.8M

Open$21.70

Beta0.83

Overview

ACADIA Pharmaceuticals Inc. (ACAD) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ACAD · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$819.7M▲ +8.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$177.7M

cashAndCashEquivalents

Short-Term Investments

$642.0M

shortTermInvestments

YoY Change vs Prior Year

+8.4%

vs prior fiscal year

Latest Quarter

$851.5M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$819.7MCash on Hand

Total Debt$52.2MTotal Debt

Net Cash / Net Debt+$767.5MNet Cash Position

Cash vs Debt Ratio

Cash 94%ACADIA Pharmaceuticals Inc. cash as % of market cap: 22.43%% · MCap $4BDebt 6%

ACADIA Pharmaceuticals Inc. has a net cash position of $767.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$819.7M − $52.2M = +$767.5M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ACAD annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ACAD cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$819.7M+8.4%

Dec 31, 2024FY$756.0M+72.3%

Dec 31, 2023FY$438.9M+5.3%

Dec 31, 2022FY$416.8M-20.0%

Dec 31, 2021FY$520.7M-17.6%

ACAD cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ACAD vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

ACADIA Pharmaceuticals Inc.YOU

ACAD

$819.7M$4B22.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

ACADIA Pharmaceuticals Inc. (ACAD) cash on hand as of December 31, 2025 is $819.7M, comprising $177.7M in cash and cash equivalents (CCE) plus $642.0M in short-term investments — reported as ACADIA Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as ACADIA Pharmaceuticals Inc. cash reserves or cash position.

ACADIA Pharmaceuticals Inc. annual cash on hand history shows increased +8.4% in 2025: increased +8.4% in 2025. ACADIA Pharmaceuticals Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

ACADIA Pharmaceuticals Inc. carries total debt of $52.2M against cash of $819.7M, resulting in a net cash position of +$767.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ACAD cash on hand · 5 questions

As of December 31, 2025, ACADIA Pharmaceuticals Inc. (ACAD) has $819,686,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $177,695,000 in cash and cash equivalents (CCE) plus $641,991,000 in short-term investments. Latest quarter (March 31, 2026): $851,458,000. Data sourced from the annual 10-K filing via FMP.

ACAD cash on handACAD cash reservesACAD cash 2025how much cash does ACAD have

▸ Source: FMP /balance-sheet-statement · US GAAP · ACADIA Pharmaceuticals Inc. · ACADIA Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025